Comparison of the dose accuracy of prefilled insulin pens

Journal of Diabetes Science and Technology

Volumn 3, Issue 1, 2009, Pages 149-153

  Weise, Alexander ^a   Pfützner, Johannes W ^a   Borig, Julia ^a   Pfützner, Anna M ^a   Safinowski, Michael ^a   Han̈el, Heike ^a   Musholt, Petra B ^a   Pfuẗzner, Andreas ^a  

^a IKFE Institute for Clinical Research and Development   (Germany)

Author keywords

Accuracy; Disposable pen; Dose delivery

Indexed keywords

INSULIN;

ARTICLE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; INSTRUMENTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

DRUG DELIVERY SYSTEMS; INJECTIONS, SUBCUTANEOUS; INSULIN;

EID: 67650674288     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300116     Document Type: Article

References (18)

1. IMS Health. Estimated number of patients using FlexPen®, based on worldwide sales in number of packs sold, IMS world wide data Q4'07 and Daily Defined Dosage (DDD) for insulin as issued by WHO. 2007
2. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med. 1999;106(5):57-8, 61-4, 68.
3. Mollema ED, Snoek FJ, Adèr HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51(5):665-72.
4. Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med. 2001;18(8):671-4.
5. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract. 1999;46(3):239-46.
6. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997;20(3):292-8.
7. Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract. 1995;41(2):169-75.
8. Glasgow RE, Fisher EB, Anderson BJ, LaGreca A, Marrero D, Johnson SB, Rubin RR, Cox DJ. Behavioral science in diabetes. Contributions and opportunities. Diabetes Care. 1999;22(5):832-43.
9. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, the International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673-9.
10. Asakura T, Seino H. Insulin dosing accuracy with FlexPen® versus syringe by healthcare professionals and healthy volunteers. Diabetes. 2005;54(Suppl 1):A498-9.
11. Asakura T, Seino H, Kageyama M, Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opinion. 2008;24(5):1429-34.
12. Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A. Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech. 2008;2(3):478-81.
13. Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res. 2005;8:33-40.
14. Penfornis A, Horvat K. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels. Diabetes Technol Ther. 2008;10(5):359-62.
15. Pfützner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin. 2008;24(9):2545-9.
16. Reimer T, Hohberg C, Jørgensen C, Jensen KH, Pfützner A. Instruction time, intuitiveness and patient acceptance of a prefilled and reusable insulin injection device - the NovoMix® 30 FlexPen® and the HumanPen® Luxura. Diabetes. 2007;56(Suppl 1):2101.
17. International Organization for Standardization. Pen-injectors for medical use - part 1: pen-injectors - requirements and test methods. ISO 11608-1:2000, Version 1. 2000.
18. Rissler J, Jørgensen C, Rye Hansen M, Hansen NA. Evaluation of injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2217-22.